Difference between revisions of "Lung Density Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
m (Round 5)
m (QIBA Funded Projects)
Line 80: Line 80:
 
====Round 5====
 
====Round 5====
 
*[[Media:Investigation of Methods of Volume Correction for Lung Density CT.pdf | Project (L) Investigation of Methods of Volume Correction for Lung Density CT (University of Wisconsin, Madison)]]
 
*[[Media:Investigation of Methods of Volume Correction for Lung Density CT.pdf | Project (L) Investigation of Methods of Volume Correction for Lung Density CT (University of Wisconsin, Madison)]]
 +
 +
====Round 6====
 +
*[[Media:Translating Phantom Harmonization to Clinical Practice.pdf | Project (U) CT Lung Density Biomarker-Translating Phantom Harmonization to Clinical Practice (National Jewish Health)]]

Revision as of 16:34, 25 March 2019

Co-chairs: Sean Fain, PhD; Matthew Fuld, PhD; David Lynch, MD
Secretary: Julie Lisiecki

Scope

Scope: Quantitative CT lung densitometry and morphology for COPD and related diseases.

Initial Objectives:

  • Characterize the precision and accuracy of phenotyping and progression measurements in emphysema and asthma.
This is an essential effort to classify phenotype and assess longitudinal changes as medically meaningful surrogates for health status.
  • Compare the sensitivity of CT measurements to spirometry and other accepted measures.
This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.

Recent Meetings/Call Summaries

Lung Density/COPD BC Call Summaries Archive

Profile Development

Status - <summarize current status>

Archive - Lung Density

Protocol Development Activities


Groundwork Activities

Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.

  • Phantom project


Working Documents


Reference Documents


QIBA Funded Projects

Round 2

Round 4

Round 5

Round 6